Computational Approaches

Adverse Effects of Engineered Nanomaterials: Exposure, Toxicology, and Impact on Human Health

Volumn , Issue , 2012, Pages 85-96

  Epa, Vidana ^a   Winkler, Dave ^a,b   Tran, Lang ^c  

^a CSIRO   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c INSTITUTE OF OCCUPATIONAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85135250212     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-386940-1.00005-2     Document Type: Chapter

References (40)

1. Hansen S.F., Maynard A., Baun A., Tickner J.A. Late lessons from early warnings for nanotechnology. Nat Nanotechnol 2008, 3:444-447.
2. Maynard A., Rejeski D. Too small to overlook. Nature 2009, 460:174.
3. Morris J., Willis J., De Martinis D., et al. Science policy considerations for responsible nanotechnology decisions. Nat Nanotechnol 2011, 6:73-77.
4. Barnard A.S. One-to-one comparison of sunscreen efficacy, aesthetics and potential nanotoxicity. Nat Nanotechnol 2010, 5:271-274.
5. Gulson B., Wong H., McCall M., et al. Dermal absorption of ZnO nanoparticles in sunscreen using the stable isotope approach. Toxicol Lett 2008, 180:S222.
6. Sakamoto Y., Nakae D., Fukumori N., et al. Induction of mesothelioma by a single intrascrotal administration of multi-wall carbon nanotube in intact male Fischer 344 rats. J Toxicol Sci 2009, 34:65-76.
7. Takagi A., Hirose A., Nishimura T., et al. Induction of mesothelioma in p53+/- mouse by intraperitoneal application of multi-wall carbon nanotube. J Toxicol Sci 2008, 33:105-116.
8. Ahlers J., Stock F., Werschkun B. Integrated testing and intelligent assessment-new challenges under REACH. Environ Sci Pollut Res 2008, 15:565-572.
9. Nabholz J.V. Environmental-hazard and risk assessment under the United-States Toxic-Substances Control Act. Sci Total Environ 1991, 109:649-665.
10. Dix D.J., Houck K.A., Martin M.T., Richard A.M., Setzer R.W., Kavlock R.J. The ToxCast program for prioritizing toxicity testing of environmental chemicals. Toxicol Sci 2007, 95:5-12.
11. Nicholson A., Sandler J., Seidle T. An evaluation of the US High Production Volume (HPV) chemical-testing programme: A study in (Ir)relevance, redundancy and retro thinking. Altern Lab Anim 2004, 32:335-341.
12. Judson R., Richard A., Dix D., et al. ACTOR-Aggregated computational toxicology resource. Toxicol Appl Pharmacol 2008, 233:7-13.
13. Brazma A. Minimum information about a microarray experiment (MIAME)-successes, failures, challenges. Sci World J 2009, 9:420-423.
14. Brazma A., Hingamp P., Quackenbush J., et al. Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat Genet 2001, 29:365-371.
15. Barnard A.S. Computational strategies for predicting the potential risks associated with nanotechnology. Nanoscale 2009, 1:89-95.
16. Barnard A.S. How can ab initio simulations address risks in nanotech?. Nat Nanotechnol 2009, 4:332-335.
17. Nel A., Xia T., Madler L., Li N. Toxic potential of materials at the nanolevel. Science 2006, 311:622-627.
18. Brayner R. The toxicological impact of nanoparticles. Nano Today 2008, 3:48-55.
19. Barnard A.S. A thermodynamic model for the shape and stability of twinned nanostructures. J Phys Chem B 2006, 110:24498-24504.
20. Barnard A.S., Xu H.F. An environmentally sensitive phase map of titania nanocrystals. ACS Nano 2008, 2:2237-2242.
21. Osmond M.J., McCall M.J. Zinc oxide nanoparticles in modern sunscreens: An analysis of potential exposure and hazard. Nanotoxicology 2010, 4:15-41.
22. Oberdorster G., Elder A., Rinderknecht A. Nanoparticles and the brain: cause for concern?. J Nanosci Nanotechnol 2009, 9:4996-5007.
23. Cappai R., Barnham K.J. Delineating the mechanism of Alzheimer's disease A beta peptide neurotoxicity. Neurochem Res 2008, 33:526-532.
24. Fourches D., Pu D.Q.Y., Tassa C., et al. Quantitative nanostructure-activity relationship modeling. ACS Nano 2010, 4:5703-5712.
25. Weissleder R., Kelly K., Sun E.Y., Shtatland T., Josephson L. Cell-specific targeting of nanoparticles by multivalent attachment of small molecules. Nat Biotechnol 2005, 23:1418-1423.
26. Shaw S.Y., Westly E.C., Pittet M.J., Subramanian A., Schreiber S.L., Weissleder R. Perturbational profiling of nanomaterial biologic activity. Proc Natl Acad Sci USA 2008, 105:7387-7392.
27. Puzyn T., Rasulev B., Gajewicz A., et al. Using nano-QSAR to predict the cytotoxicity of metal oxide nanoparticles. Nat Nanotechnol 2011, 6:175-178.
28. Burden F.R., Winkler D.A. Robust QSAR models using Bayesian regularized neural networks. J Med Chem 1999, 42:3183-3187.
29. Burden F.R., Winkler D.A. An optimal self-pruning neural network and nonlinear descriptor selection in QSAR. QSAR Combin Sci 2009, 28:1092-1097.
30. Burden F.R., Winkler D.A. Optimal sparse descriptor selection for QSAR using Bayesian methods. QSAR Combin Sci 2009, 28:645-653.
31. Figueiredo M.A.T. Adaptive sparseness for supervised learning. IEEE Transact Pattern Anal Machine Intell 2003, 25:1150-1159.
32. Mackay D.J.C. A practical Bayesian framework for backpropagation networks. Neur Comput 1992, 4:448-472.
33. Epa V.C., Burden F.R., Shaw S., Tassa C., Weissleder R., Winkler D.A. Modelling cellular uptake and apoptosis by nanoparticles. Nat Nanotechnol submitted 2011.
34. Xia X.R., Monteiro-Riviere N.A., Riviere J.E. An index for characterization of nanomaterials in biological systems. Nat Nanotechnol 2010, 5:671-675.
35. Liu R., Rallo R., George S., et al. Classification NanoSAR development for cytotoxicity of metal oxide nanoparticles. Small 2011, 7:1118-1126.
36. Liu J.Z., Hopfinger A.J. Identification of possible sources of nanotoxicity from carbon nanotubes inserted into membrane bilayers using membrane interaction quantitative structure-activity relationship analysis. Chem Res Toxicol 2008, 21:459-466.
37. MacCalman L., Tran C.L., Kuempel E. Development of a bio-mathematical model in rats to describe clearance, retention and translocation of inhaled nano particles throughout the body. Inhaled Part X 2009, 151:677.
38. Feng M.R., Lou X.C., Brown R.R., Hutchaleelaha A. Allometric pharmacokinetic scaling: Towards the prediction of human oral pharmacokinetics. Pharm Res 2000, 17:410-418.
39. Marino D.J., Starr T.B. Probabilistic dose-response modeling: Case study using dichloromethane PBPK model results. Reg Toxicol Pharmacol 2007, 49:285-300.
40. Le T.C., Epa V.C., Burden F.R., Winkler D.A. Towards predictive modelling of diverse materials properties. Accounts Chem Res Submitted 2011.